CVS Shares Plunge 12% as Two-Company Split Spooks Investors
CVS sits 15% above its 52-week low of $69.51 on elevated volume (2.8× avg).
Summary
CVS shares are down 12%, the worst one-day drop since January 27, after the company confirmed it will break itself in two. One entity will hold Aetna and Caremark; the other gets the roughly 9,000 retail pharmacies. The split is targeted for early 2028, unwinding the near-$70 billion Aetna merger completed a decade ago. The market reaction is the story here: investors are pricing the loss of the integrated model rather than rewarding the sum-of-the-parts case. This follows this morning's 8-K detailing the separation and a clean Q3 beat with revenue of $108.4 billion and adjusted EPS of $2.09.
At the time of this announcement, CVS was trading at $80.13 on NYSE in the Life Sciences sector, with a market capitalization of approximately $102.5B. The 52-week trading range was $69.51 to $110.68. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.